Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Phase I design: Dose findings in clinical trials, 3+3 design, Rolling six design. Bayesian Phase II design: LINES clinical trial, MEMOS clinical trial

Places are limited and need to be booked for this talk.

Please email to book. Please note, examples used will be Oncology based.